ReviewScience advances2026
Redox therapy for neuropsychiatric disorders: Molecular mechanisms and biomarker development.
Kyle W Cuklanz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewScience advances2026
Kyle W Cuklanz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.